Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports

Author： Wilgenhof Sofie   Four Stephanie Du   Everaert Hendrik   Neyns Bart  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.30, Iss.10, 2012-12, pp. : 712-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

By Kelderman Sander   van der Kooij Monique K.   van den Eertwegh Alfons J. M.   Soetekouw Patricia M. M. B.   Jansen Rob L. H.   van den Brom Rob R. H.   Hospers Geke A. P.   Haanen John B. A. G.   Kapiteijn Ellen   Blank Christian U.  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1786-1788

Informa Healthcare

Access to resources Recommend Favorite

Severe colitis while responding to ipilimumab in metastatic melanoma

By Slingerland Marije   Nortier Johan W. R.   Veenendaal Roeland A.   Kapiteijn Ellen  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 805-807

Informa Healthcare

Access to resources Recommend Favorite

Ipilimumab: showing survival benefit in metastatic melanoma

By Minchom Anna   Young Kate   Larkin James  

Future Oncology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1255-1264

Future Medicine

Access to resources Recommend Favorite

Docetaxel: response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer

By Archer C.D.   Lowdell C.   Sinnett H.D.   English J.   Khan S.   Coombes R.C.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 816-819

Elsevier

Access to resources Recommend Favorite

Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients

By Zambetti M.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite